{"id":"W6949277524","doi":"10.5281/zenodo.14640141","title":"PREreview of \"Safety and Efficacy of Chimeric Antigen Receptor T-cell Therapy for Recurrent Glioblastoma: An Augmented Meta-analysis of Phase 1 Clinical Trials\"","year":2025,"lang":"en","type":"peer-review","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Chimeric antigen receptor; Adverse effect; Disease; Compassionate Use; CAR T-cell therapy; Progression-free survival; Phases of clinical research; Glioblastoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07471672,0.001992696,0.006951073,0.005598883,0.0007830473,0.004748405,0.002836962,0.002611962,0.02190251],"category_scores_gemma":[0.2149244,0.001453987,0.009543692,0.004694053,0.0007250782,0.002008963,0.001951279,0.003058743,0.003577327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003552195,"about_ca_system_score_gemma":0.01053875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001950562,"about_ca_topic_score_gemma":0.006475618,"domain_scores_codex":[0.9498934,0.03325747,0.006420046,0.002053632,0.007734071,0.0006414978],"domain_scores_gemma":[0.7475423,0.1494218,0.02436241,0.01213157,0.06320529,0.003336606],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005381468,0.00008952931,0.003396562,0.3059882,0.05420177,0.0004204893,0.0002889662,0.0006503914,0.001603145,0.001135717,0.5131904,0.1136534],"study_design_scores_gemma":[0.01009505,0.002580147,0.02254779,0.1745851,0.2037454,0.0009278418,0.0003693293,0.001816157,0.002765508,0.003979199,0.5762011,0.0003872737],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.009646149,0.7780045,0.009080188,0.06802513,0.0610192,0.01744492,0.04284361,0.001205196,0.01273114],"genre_scores_gemma":[0.2088574,0.5229734,0.03965797,0.06696106,0.05560106,0.03226617,0.04147184,0.002087484,0.03012358],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.9252833,"threshold_uncertainty_score":0.3951445,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2629647973709968,"score_gpt":0.4665238097959352,"score_spread":0.2035590124249384,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}